Pavel O Bochkov (Pavel Bochkov, P O Bochkov)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Angiotensin Converting Enzyme

Oral Anticoagulants

Atrial Fibrillation

Pulmonary Embolism

Top Venues

Drug metabolism and personalized therapy

Pharmacogenomics and personalized medicine

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Yury A Surovoy, Maksim A Burkin, Inna A Galvidis, Pavel O Bochkov, Armen V Oganesyan, Sergei V Tsarenko
Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy 77 (5) (2022)
Eric Rytkin, Irina Vladimirovna Bure, Pavel O Bochkov, Kristina Anatolyevna Akmalova, Karin Badavievich Mirzaev, Marina S Cherniaeva, Olga Dmitrievna Ostroumova, Valeriy V Smirnov, Elena A Grishina, Anna G Saribekian, Igor N Sychev, Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug metabolism and personalized therapy 37 (1) (2021)
Eric Rytkin, Irina Vladimirovna Bure, Pavel O Bochkov, Kristina Anatolyevna Akmalova, Karin Badavievich Mirzaev, Marina S Cherniaeva, Olga Dmitrievna Ostroumova, Valeriy V Smirnov, Elena A Grishina, Anna G Saribekian, Igor N Sychev, Dmitry Alekseevich Sychev
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug metabolism and personalized therapy (2021)
D A Sychev, O A Baturina, K B Mirzaev, Eric Rytkin, Dmitriy V Ivashchenko, Denis Andreev, Kristina Anatolyevna Akmalova, E A Grishina, Pavel O Bochkov, Roman Shevchenko
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 13 (2020)
Dmitry Alekseevich Sychev, Karin Badavievich Mirzaev, Marina S Cherniaeva, Maria Kulikova, Pavel O Bochkov, Roman Shevchenko, Svetlana Gorbatenkova, Olga Golovina, Olga Dmitrievna Ostroumova, Damirya Bahteeva, Eric Rytkin
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation. Drug metabolism and personalized therapy (2020)
Dmitry Alekseevich Sychev, Karin Badavievich Mirzaev, Marina S Cherniaeva, Maria Kulikova, Pavel O Bochkov, Roman Shevchenko, Svetlana Gorbatenkova, Olga Golovina, Olga Dmitrievna Ostroumova, Damirya Bahteeva, Eric Rytkin
Drug-drug interaction of rivaroxaban and calcium channel blockers in patients aged 80 years and older with nonvalvular atrial fibrillation. Drug metabolism and personalized therapy 35 (3) (2020)